Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2026	Dec. 31, 2025
Fixed maturity available-for-sale securities, at fair value
Amortized Cost	$ 103,424	$ 101,462
Allowance for Credit Losses	111	110
Mortgage loans on real estate, net of allowance for credit losses
Fair value	$ 198	$ 199
Stockholders’ Equity
Preferred stock - authorized (in shares)	10,000,000	10,000,000
Preferred stock - issued (in shares)	40,000	40,000
Preferred stock - outstanding (in shares)	40,000	40,000
Common stock - authorized (in shares)	800,000,000	800,000,000
Common stock - issued (in shares)	191,209,768	190,051,477
Common stock - outstanding (in shares)	191,209,768	190,051,477
Series C Preferred Stock
Stockholders’ Equity
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000
Series D Preferred Stock
Stockholders’ Equity
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000